Company press releases

Displaying 1 - 50 of 214 results
Released Company Title Industry Topic
28 Nov 2025
08:30 CET 		INVENTIVA Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025 20103010 Biotechnology General meeting / Board Meeting
28 Nov 2025
08:30 CET 		INVENTIVA Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27 novembre 2025 20103010 Biotechnology General meeting / Board Meeting
24 Nov 2025
22:00 CET 		INVENTIVA Information relating to the stabilization activities carried out in the context of its recent offering 20103010 Biotechnology Other subject
24 Nov 2025
22:00 CET 		INVENTIVA Informations relatives aux activités de stabilisation menées dans le cadre de sa récente offre au public 20103010 Biotechnology Other subject
21 Nov 2025
22:00 CET 		INVENTIVA Inventiva reports 2025 Third Quarter Financial Information¹ 20103010 Biotechnology Other subject
21 Nov 2025
22:00 CET 		INVENTIVA Inventiva publie ses informations financières du 3ème trimestre 2025¹ 20103010 Biotechnology Other subject
17 Nov 2025
08:30 CET 		INVENTIVA Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M 20103010 Biotechnology Other subject
17 Nov 2025
08:30 CET 		INVENTIVA Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars 20103010 Biotechnology Other subject
13 Nov 2025
16:24 CET 		INVENTIVA Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris 20103010 Biotechnology Other subject
13 Nov 2025
16:24 CET 		INVENTIVA Inventiva announces trading resumption of its ordinary shares on Euronext Paris 20103010 Biotechnology Other subject
13 Nov 2025
15:21 CET 		INVENTIVA Inventiva annonce les modalités définitives ainsi que l'extension de l'offre au public d'American Depositary Shares d'approximativement 150 millions de dollars 20103010 Biotechnology Other subject
13 Nov 2025
15:21 CET 		INVENTIVA Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares 20103010 Biotechnology Other subject
13 Nov 2025
08:40 CET 		INVENTIVA Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris 20103010 Biotechnology Other subject
13 Nov 2025
08:40 CET 		INVENTIVA Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris 20103010 Biotechnology Other subject
12 Nov 2025
22:25 CET 		INVENTIVA Inventiva annonce le lancement d'une offre au public 20103010 Biotechnology Other financial transaction
12 Nov 2025
22:25 CET 		INVENTIVA Inventiva announces launch of public offering 20103010 Biotechnology Other financial transaction
06 Nov 2025
22:00 CET 		INVENTIVA Information relative au nombre total de droits de vote et d’actions composant le capital social au 20 octobre 2025 20103010 Biotechnology Other subject
06 Nov 2025
22:00 CET 		INVENTIVA Assemblée Générale Mixte du 27 novembre 2025 - Modalités de mise à disposition des documents préparatoires 20103010 Biotechnology Other subject
06 Nov 2025
22:00 CET 		INVENTIVA Statement of total voting rights and shares forming the company’s share capital as October 20, 2025 20103010 Biotechnology Other subject
06 Nov 2025
22:00 CET 		INVENTIVA Combined General Meeting of November 27, 2025 - Availability of the preparatory documents 20103010 Biotechnology Other subject
14 Oct 2025
22:00 CEST 		INVENTIVA Inventiva annonce la mise en place d’un nouveau programme « At-The-Market » (ATM) 20103010 Biotechnology Other subject
14 Oct 2025
22:00 CEST 		INVENTIVA Inventiva Announces the Implementation of a New ATM Program 20103010 Biotechnology Other subject
07 Oct 2025
22:00 CEST 		INVENTIVA Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025 20103010 Biotechnology Other subject
07 Oct 2025
22:00 CEST 		INVENTIVA Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025 20103010 Biotechnology Other subject
01 Oct 2025
08:30 CEST 		INVENTIVA Inventiva Appoints Andrew Obenshain as Chief Executive Officer 20103010 Biotechnology Corporate life
01 Oct 2025
08:30 CEST 		INVENTIVA Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général 20103010 Biotechnology Corporate life
29 Sep 2025
08:30 CEST 		INVENTIVA Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update   20103010 Biotechnology Other subject
29 Sep 2025
08:30 CEST 		INVENTIVA Inventiva publie ses résultats financiers non audités du premier semestre 2025 et fait le point sur ses activités 20103010 Biotechnology Other subject
24 Sep 2025
22:00 CEST 		INVENTIVA Inventiva organise un événement analystes et investisseurs le 8 octobre 2025 20103010 Biotechnology Other subject
24 Sep 2025
22:00 CEST 		INVENTIVA Inventiva to Host Analyst and Investor Event on October 8, 2025 20103010 Biotechnology Other subject
04 Sep 2025
22:00 CEST 		INVENTIVA Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre 20103010 Biotechnology Other subject
04 Sep 2025
22:00 CEST 		INVENTIVA Inventiva to Participate in Upcoming September Investor Conferences 20103010 Biotechnology Other subject
11 Aug 2025
22:00 CEST 		INVENTIVA Inventiva Participera à la « Canaccord Genuity 45th Annual Growth Conference » 20103010 Biotechnology Other subject
11 Aug 2025
22:00 CEST 		INVENTIVA Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference 20103010 Biotechnology Other subject
31 Jul 2025
22:00 CEST 		INVENTIVA Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux 20103010 Biotechnology Other subject
31 Jul 2025
22:00 CEST 		INVENTIVA Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux 20103010 Biotechnology Other subject
29 Jul 2025
22:00 CEST 		INVENTIVA Inventiva Reports Preliminary 2025 First-Half Financial Information¹ 20103010 Biotechnology Other subject
29 Jul 2025
22:00 CEST 		INVENTIVA Inventiva publie ses informations financières préliminaires du premier semestre 2025¹ 20103010 Biotechnology Other subject
09 Jul 2025
22:05 CEST 		INVENTIVA Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité 20103010 Biotechnology Other subject
09 Jul 2025
22:05 CEST 		INVENTIVA Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance 20103010 Biotechnology Other subject
07 Jul 2025
22:00 CEST 		INVENTIVA Inventiva receives $10 million milestone payment from CTTQ 20103010 Biotechnology Other subject
07 Jul 2025
22:00 CEST 		INVENTIVA Inventiva receives $10 million milestone payment from CTTQ 20103010 Biotechnology Other subject
02 Jul 2025
22:00 CEST 		INVENTIVA Inventiva annonce la publication dans le Journal of Hepatology Reports des résultats du lanifibranor sur les cellules endothéliales sinusoïdales hépatiques chez des patients MASLD/MASH et dans des modèles précliniques de la maladie 20103010 Biotechnology Other subject
02 Jul 2025
22:00 CEST 		INVENTIVA Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease 20103010 Biotechnology Other subject
10 Jun 2025
22:00 CEST 		INVENTIVA Inventiva Annonce la Nomination de Renée Aguiar-Lucander à son Conseil d’Administration 20103010 Biotechnology Other subject
10 Jun 2025
22:00 CEST 		INVENTIVA Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors 20103010 Biotechnology Other subject
27 May 2025
22:00 CEST 		INVENTIVA Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference 20103010 Biotechnology Other subject
27 May 2025
22:00 CEST 		INVENTIVA Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference » 20103010 Biotechnology Other subject
23 May 2025
08:30 CEST 		INVENTIVA Inventiva publie ses informations financières¹ du 1er trimestre 2025 20103010 Biotechnology Other subject
23 May 2025
08:30 CEST 		INVENTIVA Inventiva reports 2025 First Quarter Financial Information¹ 20103010 Biotechnology Other subject